Eric Nepute alias Dr. BioLimitless Bro
Website · ericnepute.com
Practice location
4225 BAYLESS AVE
SAINT LOUIS, MO 63123
Funnel-first framing that runs on persuasion, light on published evidence.
Oh, look at Eric Nepute, the 'Doctor of Three' who's so busy stacking unverified titles he forgot to get an MD license! He's out here claiming to fix your brain, your gut, and your hormones with 'functional neurology' and 'peptide therapies'—all while selling you his own BioLimitless supplements to pay for the 'root-cause' he just diagnosed. Truly, the king of 'wellness freedom' who freedom from audits and medical oversight!
High grift signals
Score breakdown
Direct answer
Eric Nepute is licensed in Missouri as a chiropractor (DC), not as an MD or DO, and Missouri's chiropractic scope statute (RSMo § 331.010) limits that license to musculoskeletal care, not the diagnosis or treatment of systemic disease. Even so, they advertise diagnosing or treating Functional Neurology, Internal Health, Peptide therapies, Root-cause solutions, and Natural medicine, conditions that belong with appropriately board-certified physicians. Those same pages route patients toward supplements and paid programs that Eric Nepute profits from.
Key findings
- False Authority: The subject stacks three 'Doctor' titles, where only one (Chiropractic) is a state-licensed medical degree. The other two (Functional Medicine, Functional Neurology) are unverified or non-clinical titles used to imply broad medical authority beyond the narrow scope of a…see section ↓
- Claim "Functional Neurology": not supported by peer-reviewed evidence.see section ↓
- Claim "Internal Health": not supported by peer-reviewed evidence.see section ↓
- NPI registry confirms Eric Nepute as Chiropractor (DC) in Missouri (NPI 1790833044).see section ↓
- Eric Nepute shows credential inflation relative to stated vs likely credentials.see section ↓
- Dr Eric Nepute is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
- Against Missouri State Board of Chiropractic Examiners scope rules (RSMo § 331.010), these advertised activities appear outside Eric Nepute's license (including conditions they merely list as ones they treat): Claiming to treat 'root causes' of chronic diseases (autoimmune, metabolic) which is…see section ↓
- 8 of 12 advertised activities fall outside permitted Chiropractor scope in MO.see section ↓
Claims & evidence
9 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Eric Nepute is not licensed or approved by Missouri State Board of Chiropractic Examiners to diagnose, treat, or cure Functional Neurology.
Functional Neurology
- Supports
- No high-quality evidence in the provided index papers supports the broad claim of Functional Neurology as a valid, evidence-based medical approach. The closest indexed paper is a systematic review and meta-analysis about functional outcomes after pediatric intracranial arteriovenous malformation intervention, but it addresses neurologic outcome measurement, not the Functional Neurology practice itself . [1][2][3]
- Contradicts
- The provided index set contains no systematic review, meta-analysis, randomized controlled trial, or major guideline demonstrating that Functional Neurology is effective for diagnosing or treating neurologic disorders. The indexed papers are unrelated clinical topics, so they do not substantiate the claim . [1][2][3] In mainstream academic medicine, Functional Neurology is generally not recognized as a standard evidence-based specialty; its specific interventions have not been established by robust clinical trials or guidelines. Evidence for many claims made under that label remains sparse, heterogeneous, or absent.
- Mainstream view
- The mainstream medical view is that Functional Neurology is not an established evidence-based diagnostic or treatment system. Where individual techniques overlap with legitimate rehabilitation, vestibular therapy, migraine management, or neurorehabilitation, those components may have evidence, but the umbrella Functional Neurology claim is not supported as a whole by high-quality evidence. [1][2][3]
“Doctor of Functional Neurology”
Rule: RSMo § 331.010
Eric Nepute is not licensed or approved by Missouri State Board of Chiropractic Examiners to diagnose, treat, or cure Internal Health.
Internal Health
- Supports
- The influencer’s phrase “internal health” is too vague to map onto a specific clinical intervention, disease, or measurable outcome, so no high‑quality trials, systematic reviews, or guidelines in the provided index directly evaluate or endorse a construct called “internal health” as used in wellness marketing. The indexed items instead concern specific conditions (e. [5][6][7][1][2][8] g. , chronic hepatitis C genotype 4, depression in heart failure, prostate cancer radiotherapy) or health‑system processes, each with their own evidence base, but none define or validate a global marketing concept of “internal health”. [4] Major guideline-development methodology emphasizes using systematic reviews tied to clearly defined clinical questions and outcomes rather than broad, ill‑defined constructs, reinforcing that evidence-based practice does not generally operate around vague terms like “internal health”.
- Contradicts
- Because “internal health” is undefined, there is no direct evidence refuting a clearly specified claim; the problem is that the claim lacks operationalization and measurable endpoints, preventing rigorous testing or falsification. [4] High‑quality evidence and guideline methodology highlight that clinically useful concepts must be linked to specific organs, systems, diseases, risk factors, or interventions, not to undifferentiated wellness slogans, so the influencer framing is misaligned with how evidence-based medicine works. Studies on health misinformation and influencer promotion of tests or interventions with limited evidence show that social media often exaggerates benefits and downplays harms for loosely framed ideas such as “gut health” or “health from within”, which is closely analogous to “internal health”, suggesting the influencer rhetoric is likely weakly evidenced and potentially misleading. General academic and journalistic analyses of influencer-promoted health trends indicate that such terms are typically marketing language rather than constructs grounded in randomized trials, meta-analyses, or major guidelines. In the absence of a precise definition, any strong causal claims (e. g. , that a product or practice reliably improves “internal health”) should be regarded as unsupported.
- Mainstream view
- Mainstream medicine does not recognize “internal health” as a defined diagnostic category, outcome measure, or guideline concept; instead, it focuses on specific domains such as cardiovascular health, metabolic health, mental health, or clearly described risk factors and diseases, each supported by targeted evidence. Internal medicine as a specialty is concerned with prevention, diagnosis, and treatment of adult diseases of internal organs, not with a generic marketing construct of “internal health”. [4] Clinicians and guideline developers rely on systematic reviews and well-specified clinical questions, and they generally view broad, unmeasured wellness claims with skepticism unless they can be translated into defined outcomes like blood pressure reduction, improved glycemic control, or decreased symptom burden. Public health and evidence-based practice communities increasingly warn that influencer-driven health narratives often use vague terms (like “detox”, “reset”, “internal health”) that are not grounded in rigorous clinical endpoints, and advise critical appraisal and reliance on established preventive measures (e. g. , healthy diet, physical activity, vaccination, evidence-based screening) rather than products or regimens marketed under such labels.
“Fellowship in Internal Health”
Rule: RSMo § 331.010
Eric Nepute is not licensed or approved by Missouri State Board of Chiropractic Examiners to diagnose, treat, or cure Peptide therapies.
Peptide therapies
- Supports
- Peptide therapies are an established class of medical treatments, with numerous approved peptide drugs (for example GLP-1 receptor agonists like liraglutide, exenatide, and fixed combinations such as insulin glargine–lixisenatide) and many more in clinical trials, demonstrating that peptides can be effective and safe for specific, well-defined indications when evaluated in rigorous studies.[11][12] Randomized controlled trials show benefits of peptide-based interventions in defined diseases, such as liraglutide improving psoriasis skin lesions in patients with type 2 diabetes, along with histopathologic and inflammatory marker improvements and acceptable safety.[13] GLP-1 receptor agonist combinations (e.g., insulin glargine–lixisenatide) improve glycemic control, reduce weight, and lower hypoglycemia risk compared with premix insulin in type 2 diabetes in RCTs, supporting their therapeutic value as peptide-based drugs.[17] In oncology, personalized peptide vaccines have shown promising improvements in progression-free and overall survival in phase 2 trials for castration-resistant prostate cancer, suggesting that peptide immunotherapies can confer clinically meaningful benefit though larger phase 3 trials are needed.[4][5][10] Systematic review and meta-analysis of oral and topical peptides for skin aging report modest but statistically significant improvements in hydration, wrinkle reduction, and brightness with good tolerability, indicating at least adjunctive cosmetic efficacy, though heterogeneity is high and formulations are not standardized.[1][3] Peptides such as vasoactive intestinal peptide (Aviptadil) have been evaluated in multicenter RCTs in critical COVID-19 respiratory failure, showing a survival benefit at 60 days with an acceptable safety profile despite a neutral primary endpoint, further illustrating that peptide therapeutics can have clinically relevant effects in some contexts.[15]
- Contradicts
- The generic influencer-style claim of “peptide therapies” as broadly beneficial is not supported by high-quality evidence across all uses; instead, evidence is indication-specific and often limited to small or early-phase trials, meaning that many promoted uses (e.g., for generalized longevity, athletic enhancement, or broad wellness) lack robust RCTs or meta-analyses. Even where peptide therapies show promise, trial data frequently reveal important limitations: personalized peptide vaccines in prostate cancer demonstrated benefit in a small phase 2 trial but require larger phase 3 confirmation before being considered standard of care.[4][5][10] Cosmetic and anti-aging applications of oral and topical peptides show only modest effects with high study heterogeneity and insufficient standardization, so their real-world impact is likely limited; current evidence is inadequate to support strong claims of dramatic rejuvenation or broad systemic benefits.[1][3] Some peptide interventions fail to meet primary endpoints in RCTs or show only subgroup or secondary outcome benefits, highlighting uncertainty about true clinical efficacy; for example, Aviptadil in critical COVID-19 did not significantly improve the prespecified primary composite endpoint, and survival benefits arose from secondary analyses.[15] Historical trials such as peptide T for HIV-associated cognitive impairment found no significant difference versus placebo on primary neurocognitive outcomes, with only exploratory subgroup signals, underscoring that not all peptides are effective therapies despite biologic plausibility.[7] Major general medical guidelines indexed here (e.g., hypertension, clinical nutrition in IBD, ASPEN-FELANPE nutrition guidance) do not recommend broad “peptide therapy” as a routine treatment modality outside specific, well-studied peptide drugs (such as GLP-1 receptor agonists), suggesting that many marketed peptide injections and supplements lie outside guideline-based practice.[0][1][2]
- Mainstream view
- The mainstream medical position is that peptide therapies are a heterogeneous group of interventions ranging from highly validated, guideline-supported drugs (for example GLP-1 receptor agonists and other approved peptide medications) to experimental vaccines and supplements whose benefits and risks are not yet fully established.[11][12][13][17] In evidence-based practice, peptides are used when there is clear, indication-specific data from randomized trials and regulatory approval, such as in type 2 diabetes, certain endocrine and metabolic disorders, some cancers, and select infectious or inflammatory conditions.[4][5][10][13][15][17] Cosmetic and wellness-oriented peptide products (including many oral and injectable formulations promoted by influencers for anti-aging, performance, or general health) are generally regarded as lacking sufficient high-quality evidence, and their use is considered off-label, experimental, or adjunctive at best, with clinicians emphasizing the need for more robust RCTs and long-term safety data.[1][3] Major guidelines in common conditions (hypertension, IBD, clinical nutrition, and others) focus on established pharmacologic and nutritional strategies and do not
“discussions on health, genetics, psychology, peptide therapies, sports medicine”
Rule: RSMo § 331.010
Eric Nepute is not licensed or approved by Missouri State Board of Chiropractic Examiners to diagnose, treat, or cure Root-cause solutions.
Root-cause solutions
- Supports
- The claim is too vague to be directly supported by any specific clinical evidence because it does not define a condition, intervention, mechanism, or outcome. One index paper is a systematic review and meta-analysis on albumin in sepsis, which addresses a specific treatment question rather than a general "root-cause solutions" concept .
- Contradicts
- There is no high-quality evidence in the provided index list that supports a broad, one-size-fits-all idea of "root-cause solutions" across health conditions. The listed papers are disease- or intervention-specific trials and reviews, and several are unrelated to the claim's broad framing, so they do not substantiate it as stated. A vague wellness claim of root-cause resolution is generally not testable without specifying the underlying diagnosis and measurable endpoint.
- Mainstream view
- Mainstream medicine does not recognize "root-cause solutions" as a standalone evidence-based treatment category. Clinicians generally require a defined diagnosis, plausible mechanism, and condition-specific evidence from randomized trials, systematic reviews, or guidelines before accepting a therapeutic claim. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“dedicated to helping individuals take control of their health through personalized care, root-cause solutions”
Rule: RSMo § 331.010
Eric Nepute is not licensed or approved by Missouri State Board of Chiropractic Examiners to diagnose, treat, or cure Natural medicine.
Natural medicine
- Supports
- The influencer’s claim is extremely vague (“Natural medicine”) and not tied to a specific condition, therapy, or outcome, which makes direct evidence mapping difficult. [15] Nonetheless, there is some evidence suggesting that certain forms of naturopathic or “natural” medicine (e. g. , whole‑system naturopathy, herbal medicine, acupuncture, lifestyle-focused care) can provide benefits for specific chronic conditions when evaluated in controlled studies and systematic reviews. [17] Multiple systematic and scoping reviews of whole-system naturopathic medicine report that naturopathic care can improve clinical and patient-reported outcomes (such as pain, cardiovascular risk factors, HbA1c, anxiety, and quality of life) in chronic conditions including cardiovascular disease, type 2 diabetes, musculoskeletal pain, anxiety, and depression, though the evidence base is relatively small and heterogeneous. [1][2][16][19] External systematic reviews and overviews of Chinese herbal medicine and other traditional herbal medicines show evidence of benefit for some specific indications (e. [18] g. , irritable bowel syndrome, certain cardiac arrhythmias), again with variable quality and frequent methodological limitations. Large chronic disease guidelines increasingly acknowledge the role of lifestyle, nutrition, physical activity, psychotherapy, and other non-pharmacologic interventions, some of which overlap conceptually with “natural” approaches, as integral components of evidence-based care. [9]
- Contradicts
- The key contradiction to a broad, unqualified claim of “Natural medicine” being generally effective or preferable is that high-quality evidence is limited, mixed, and very condition-specific. Systematic reviews of whole-system naturopathy and government-sponsored evidence evaluations consistently rate the certainty of evidence as very low to low for many outcomes across diverse chronic diseases, emphasizing small sample sizes, risk of bias, and heterogeneity in practice and training. [15][16][17][19] Major evidence-based clinical guidelines for common conditions such as hypertension, inflammatory bowel disease, and critical illness nutrition are built around pharmacologic treatments, medical devices, and structured lifestyle interventions, not around general “natural medicine” or naturopathy as a primary therapy, reflecting that robust RCT and guideline-level support for natural medicine as a whole system is lacking. [9][1][2] Cochrane and similar reviews of herbal and other natural therapies frequently highlight that positive findings often come from trials with inadequate methodology, small samples, and lack of replication, and therefore cannot support broad claims of efficacy. [18] Safety data for many natural products and systems are incomplete, and potential interactions with conventional drugs and risks of delayed effective treatment are ongoing concerns in mainstream assessments. Overall, the evidence contradicts any blanket assertion that natural medicine is broadly validated, superior to, or a replacement for conventional evidence‑based care across conditions.
- Mainstream view
- The mainstream medical position is that some specific interventions often labeled as “natural” (e. g. , certain herbal preparations, acupuncture, structured diet and exercise programs, cognitive-behavioral therapy, and other non-pharmacologic modalities) can be evidence-based and valuable when supported by high-quality trials and integrated into conventional care, but “natural medicine” or naturopathy as a generalized concept is not accepted as uniformly effective or as a stand-alone alternative to guideline-directed treatment. [9][18] For major chronic and acute diseases, clinical practice is guided by large randomized controlled trials, meta-analyses, and formal guidelines that prioritize proven pharmacologic, surgical, radiotherapeutic, and structured behavioral interventions; natural or complementary therapies are considered on a case-by-case basis where evidence supports their use, often as adjuncts rather than replacements. [1][17][19] Mainstream bodies emphasize that claims for natural medicine must be evaluated with the same rigor as any other intervention and that broad, non-specific endorsements (“natural medicine works”) go beyond what current evidence can justify. [15][16]
“leader in natural medicine and functional wellness”
Rule: RSMo § 331.010
Eric Nepute is not licensed or approved by Missouri State Board of Chiropractic Examiners to diagnose, treat, or cure Prescribing or managing peptide therapies (hormone/endocrine treatment) which is outside chiropractic scope..
Prescribing or managing peptide therapies (hormone/endocrine treatment) which is outside chiropractic scope.
- Supports
- Peptide therapies are an established class of medical treatments, with numerous approved peptide drugs (for example GLP-1 receptor agonists like liraglutide, exenatide, and fixed combinations such as insulin glargine–lixisenatide) and many more in clinical trials, demonstrating that peptides can be effective and safe for specific, well-defined indications when evaluated in rigorous studies.[11][12] Randomized controlled trials show benefits of peptide-based interventions in defined diseases, such as liraglutide improving psoriasis skin lesions in patients with type 2 diabetes, along with histopathologic and inflammatory marker improvements and acceptable safety.[13] GLP-1 receptor agonist combinations (e.g., insulin glargine–lixisenatide) improve glycemic control, reduce weight, and lower hypoglycemia risk compared with premix insulin in type 2 diabetes in RCTs, supporting their therapeutic value as peptide-based drugs.[17] In oncology, personalized peptide vaccines have shown promising improvements in progression-free and overall survival in phase 2 trials for castration-resistant prostate cancer, suggesting that peptide immunotherapies can confer clinically meaningful benefit though larger phase 3 trials are needed.[4][5][10] Systematic review and meta-analysis of oral and topical peptides for skin aging report modest but statistically significant improvements in hydration, wrinkle reduction, and brightness with good tolerability, indicating at least adjunctive cosmetic efficacy, though heterogeneity is high and formulations are not standardized.[1][3] Peptides such as vasoactive intestinal peptide (Aviptadil) have been evaluated in multicenter RCTs in critical COVID-19 respiratory failure, showing a survival benefit at 60 days with an acceptable safety profile despite a neutral primary endpoint, further illustrating that peptide therapeutics can have clinically relevant effects in some contexts.[15]
- Contradicts
- The generic influencer-style claim of “peptide therapies” as broadly beneficial is not supported by high-quality evidence across all uses; instead, evidence is indication-specific and often limited to small or early-phase trials, meaning that many promoted uses (e.g., for generalized longevity, athletic enhancement, or broad wellness) lack robust RCTs or meta-analyses. Even where peptide therapies show promise, trial data frequently reveal important limitations: personalized peptide vaccines in prostate cancer demonstrated benefit in a small phase 2 trial but require larger phase 3 confirmation before being considered standard of care.[4][5][10] Cosmetic and anti-aging applications of oral and topical peptides show only modest effects with high study heterogeneity and insufficient standardization, so their real-world impact is likely limited; current evidence is inadequate to support strong claims of dramatic rejuvenation or broad systemic benefits.[1][3] Some peptide interventions fail to meet primary endpoints in RCTs or show only subgroup or secondary outcome benefits, highlighting uncertainty about true clinical efficacy; for example, Aviptadil in critical COVID-19 did not significantly improve the prespecified primary composite endpoint, and survival benefits arose from secondary analyses.[15] Historical trials such as peptide T for HIV-associated cognitive impairment found no significant difference versus placebo on primary neurocognitive outcomes, with only exploratory subgroup signals, underscoring that not all peptides are effective therapies despite biologic plausibility.[7] Major general medical guidelines indexed here (e.g., hypertension, clinical nutrition in IBD, ASPEN-FELANPE nutrition guidance) do not recommend broad “peptide therapy” as a routine treatment modality outside specific, well-studied peptide drugs (such as GLP-1 receptor agonists), suggesting that many marketed peptide injections and supplements lie outside guideline-based practice.[0][1][2]
- Mainstream view
- The mainstream medical position is that peptide therapies are a heterogeneous group of interventions ranging from highly validated, guideline-supported drugs (for example GLP-1 receptor agonists and other approved peptide medications) to experimental vaccines and supplements whose benefits and risks are not yet fully established.[11][12][13][17] In evidence-based practice, peptides are used when there is clear, indication-specific data from randomized trials and regulatory approval, such as in type 2 diabetes, certain endocrine and metabolic disorders, some cancers, and select infectious or inflammatory conditions.[4][5][10][13][15][17] Cosmetic and wellness-oriented peptide products (including many oral and injectable formulations promoted by influencers for anti-aging, performance, or general health) are generally regarded as lacking sufficient high-quality evidence, and their use is considered off-label, experimental, or adjunctive at best, with clinicians emphasizing the need for more robust RCTs and long-term safety data.[1][3] Major guidelines in common conditions (hypertension, IBD, clinical nutrition, and others) focus on established pharmacologic and nutritional strategies and do not
“discussions on health, genetics, psychology, peptide therapies, sports medicine”
Rule: RSMo § 331.010
Eric Nepute is not licensed or approved by Missouri State Board of Chiropractic Examiners to diagnose, treat, or cure Functional Neurology for neurological disease.
Functional Neurology for neurological disease
- Supports
- No high-quality evidence in the provided index papers supports the broad claim of Functional Neurology as a valid, evidence-based medical approach. The closest indexed paper is a systematic review and meta-analysis about functional outcomes after pediatric intracranial arteriovenous malformation intervention, but it addresses neurologic outcome measurement, not the Functional Neurology practice itself . [1][2][3]
- Contradicts
- The provided index set contains no systematic review, meta-analysis, randomized controlled trial, or major guideline demonstrating that Functional Neurology is effective for diagnosing or treating neurologic disorders. The indexed papers are unrelated clinical topics, so they do not substantiate the claim . [1][2][3] In mainstream academic medicine, Functional Neurology is generally not recognized as a standard evidence-based specialty; its specific interventions have not been established by robust clinical trials or guidelines. Evidence for many claims made under that label remains sparse, heterogeneous, or absent.
- Mainstream view
- The mainstream medical view is that Functional Neurology is not an established evidence-based diagnostic or treatment system. Where individual techniques overlap with legitimate rehabilitation, vestibular therapy, migraine management, or neurorehabilitation, those components may have evidence, but the umbrella Functional Neurology claim is not supported as a whole by high-quality evidence. [1][2][3]
“Doctor of Functional Neurology”
Rule: RSMo § 331.010
Eric Nepute is not licensed or approved by Missouri State Board of Chiropractic Examiners to advertise Internal Health for systemic disease as within their scope of practice.
Internal Health for systemic disease
- Supports
- The influencer’s phrase “internal health” is too vague to map onto a specific clinical intervention, disease, or measurable outcome, so no high‑quality trials, systematic reviews, or guidelines in the provided index directly evaluate or endorse a construct called “internal health” as used in wellness marketing. The indexed items instead concern specific conditions (e. [5][6][7][1][2][8] g. , chronic hepatitis C genotype 4, depression in heart failure, prostate cancer radiotherapy) or health‑system processes, each with their own evidence base, but none define or validate a global marketing concept of “internal health”. [4] Major guideline-development methodology emphasizes using systematic reviews tied to clearly defined clinical questions and outcomes rather than broad, ill‑defined constructs, reinforcing that evidence-based practice does not generally operate around vague terms like “internal health”.
- Contradicts
- Because “internal health” is undefined, there is no direct evidence refuting a clearly specified claim; the problem is that the claim lacks operationalization and measurable endpoints, preventing rigorous testing or falsification. [4] High‑quality evidence and guideline methodology highlight that clinically useful concepts must be linked to specific organs, systems, diseases, risk factors, or interventions, not to undifferentiated wellness slogans, so the influencer framing is misaligned with how evidence-based medicine works. Studies on health misinformation and influencer promotion of tests or interventions with limited evidence show that social media often exaggerates benefits and downplays harms for loosely framed ideas such as “gut health” or “health from within”, which is closely analogous to “internal health”, suggesting the influencer rhetoric is likely weakly evidenced and potentially misleading. General academic and journalistic analyses of influencer-promoted health trends indicate that such terms are typically marketing language rather than constructs grounded in randomized trials, meta-analyses, or major guidelines. In the absence of a precise definition, any strong causal claims (e. g. , that a product or practice reliably improves “internal health”) should be regarded as unsupported.
- Mainstream view
- Mainstream medicine does not recognize “internal health” as a defined diagnostic category, outcome measure, or guideline concept; instead, it focuses on specific domains such as cardiovascular health, metabolic health, mental health, or clearly described risk factors and diseases, each supported by targeted evidence. Internal medicine as a specialty is concerned with prevention, diagnosis, and treatment of adult diseases of internal organs, not with a generic marketing construct of “internal health”. [4] Clinicians and guideline developers rely on systematic reviews and well-specified clinical questions, and they generally view broad, unmeasured wellness claims with skepticism unless they can be translated into defined outcomes like blood pressure reduction, improved glycemic control, or decreased symptom burden. Public health and evidence-based practice communities increasingly warn that influencer-driven health narratives often use vague terms (like “detox”, “reset”, “internal health”) that are not grounded in rigorous clinical endpoints, and advise critical appraisal and reliance on established preventive measures (e. g. , healthy diet, physical activity, vaccination, evidence-based screening) rather than products or regimens marketed under such labels.
“Fellowship in Internal Health”
Rule: RSMo § 331.010
Eric Nepute is not licensed or approved by Missouri State Board of Chiropractic Examiners to advertise Root-cause solutions for chronic disease as within their scope of practice.
Root-cause solutions for chronic disease
- Supports
- The claim is too vague to be directly supported by any specific clinical evidence because it does not define a condition, intervention, mechanism, or outcome. One index paper is a systematic review and meta-analysis on albumin in sepsis, which addresses a specific treatment question rather than a general "root-cause solutions" concept .
- Contradicts
- There is no high-quality evidence in the provided index list that supports a broad, one-size-fits-all idea of "root-cause solutions" across health conditions. The listed papers are disease- or intervention-specific trials and reviews, and several are unrelated to the claim's broad framing, so they do not substantiate it as stated. A vague wellness claim of root-cause resolution is generally not testable without specifying the underlying diagnosis and measurable endpoint.
- Mainstream view
- Mainstream medicine does not recognize "root-cause solutions" as a standalone evidence-based treatment category. Clinicians generally require a defined diagnosis, plausible mechanism, and condition-specific evidence from randomized trials, systematic reviews, or guidelines before accepting a therapeutic claim. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“dedicated to helping individuals take control of their health through personalized care, root-cause solutions”
Rule: RSMo § 331.010
Manipulation
False Authority
transcript · cited
The subject stacks three 'Doctor' titles, where only one (Chiropractic) is a state-licensed medical degree. The other two (Functional Medicine, Functional Neurology) are unverified or non-clinical titles used to imply broad medical authority beyond the narrow scope of a chiropractor. Likely motive: To convince patients they are seeing a general physician capable of treating any disease, not just a spine specialist.
“Dr. Eric Nepute is a Doctor of Chiropractic, Doctor of Functional Medicine, and Doctor of Functional Neurology.”
False Authority
transcript · cited
Quantum University is not a recognized medical school for clinical practice. This degree is used to inflate the subject's credentials and imply a medical license they do not hold. Likely motive: To bypass the need for an MD/DO license while still advertising as a 'Doctor' treating medical conditions.
“Doctorate of Natural Medicine, Quantum University, May 2011”
Sales Funnel Motive
transcript · cited
The subject is the executive of a company selling supplements and services, creating a direct financial incentive to diagnose 'problems' that require their proprietary products. Likely motive: To drive sales of BioLimitless supplements by framing them as essential 'root-cause' solutions.
“Chief Visionary Officer for BioLimitless and its associated ventures, focusing on products, services, physical health center locations”
Testimonial Overload
transcript · cited
An unverifiable, massive claim of patient success used to create a false sense of authority and efficacy without providing specific data or peer-reviewed evidence. Likely motive: To overwhelm skepticism with a narrative of massive success.
“has helped hundreds of thousands of patients discover health, many for the first time”
Commerce & grift map
Eric Nepute uses inflated 'Doctor' titles to claim authority over systemic diseases (neurology, internal health) outside his chiropractic scope, then directs patients to his proprietary BioLimitless supplement shop. The lack of FTC disclosure on the shop link hides the financial incentive, creating a funnel where 'root-cause' diagnoses lead directly to his own product sales.
BioLimitless
Supplement / product
Nepute is the Chief Visionary Officer and likely receives 100% of the profit from BioLimitless supplement sales, creating a massive financial incentive to diagnose 'problems' that require their products.
Doc Bro outbound link (live) · Archive pending
Supplements pitched
- BioLimitless Wellness Products
“Purchase high-quality wellness products, supplements and books to support your health.”
How the money flows
- Proprietary productUndisclosed Subject is Chief Visionary Officer of BioLimitless, selling proprietary supplements directly. “Chief Visionary Officer for BioLimitless and its associated ventures, focusing on products, services...”
“Chief Visionary Officer for BioLimitless and its associated ventures, focusing on products, services...”
- Affiliate / promo linkUndisclosed Link to shop page for BioLimitless products without disclosure. “Learn More”
“Learn More”
Store links detected
- Learn MoreHigh likelihood
“Subject is Chief Visionary Officer of BioLimitless”
Sponsors and advertisers
Brands, advertisers, and agencies connected to this content, based on what it promotes and discloses.
- BioLimitlessBrand
Promoted commerce partner
- BioLimitless Wellness ProductsBrand
Named on a surface without a compensation disclosure
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Stated: DR · Likely: Chiropractor
Verified against the federal provider registry: D.C. · Chiropractor · MO license 200700308.
Eric Nepute holds a legitimate Chiropractic license (Chiropractor) but inflates his credentials by adding unverified 'Doctor' titles (Functional Medicine, Functional Neurology, Natural Medicine) to imply he is a general physician capable of treating systemic diseases, which is outside his licensed scope.
- DC, Doctor of Chiropractic
A state-licensed degree focused on the diagnosis and treatment of spinal and musculoskeletal conditions. Scope is limited to the spine, nervous system, and musculoskeletal system.
Chiropractic boards typically allow diagnosis and treatment of musculoskeletal/spine conditions only. They do NOT allow diagnosis or treatment of systemic internal diseases (cancer, diabetes, autoimmune, hormonal imbalances), prescribing pharmaceuticals, or managing peptide therapies.
Permitted scope vs advertised
Missouri State Board of Chiropractic Examiners · Confidence: high
Missouri defines the practice of chiropractic as examination, diagnosis, adjustment, manipulation, and treatment by methods commonly taught in accredited chiropractic programs. The statute excludes operative surgery, obstetrics, osteopathy, podiatry, the administration or prescribing of drugs or medicine, and the practice of medicine, while allowing meridian therapy/acupressure/acupuncture with board certification.[2][4]
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
12 of 12 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Claiming to treat 'root causes' of chronic diseases (autoimmune, metabolic) which is outside chiropractic scope. Rule: RSMo § 331.010 Missouri chiropractic scope is limited to chiropractic examination, diagnosis, adjustment, manipulation, and treatment, and excludes the practice of medicine, which makes chronic systemic disease treatment claims outside the statute’s affirmative authorization.[2][4] | Outside scope |
| Listed service Functional Neurology Rule: RSMo § 331.010 The statute only affirmatively authorizes chiropractic methods commonly taught in chiropractic programs and does not affirmatively authorize neurologic specialty practice or disease-focused neurology treatment.[2][4] | Outside scope |
| Listed service Internal Health Rule: RSMo § 331.010 Missouri’s chiropractic statute does not affirmatively authorize internal medicine or general internal-health management, and it excludes the practice of medicine.[2][4] | Outside scope |
| Listed service Peptide therapies Rule: RSMo § 331.010 Peptide therapy is a drug-like medical treatment, and Missouri expressly prohibits chiropractors from administering or prescribing any drug or medicine.[2][4] | Outside scope |
| Listed service Root-cause solutions Rule: RSMo § 331.010 This is a broad disease-management claim, and Missouri chiropractic scope does not affirmatively authorize general medical treatment of underlying disease causes beyond chiropractic methods.[2][4] | Outside scope |
| Listed service Natural medicine Rule: RSMo § 331.010 Missouri’s statute does not affirmatively authorize naturopathic or general natural-medicine practice for chiropractors, and it excludes drug/medicine administration and the practice of medicine.[2][4] | Outside scope |
| Diagnosing and treating neurological diseases (brain function, cognitive health) beyond musculoskeletal scope. Rule: RSMo § 331.010 The statute authorizes chiropractic diagnosis and treatment, but it does not affirmatively authorize diagnosis or treatment of neurological disease or cognitive disorders as medical conditions.[2][4] | Outside scope |
| Diagnosing and treating systemic internal diseases (gut, organ, metabolic) beyond musculoskeletal scope. Rule: RSMo § 331.010 Systemic internal disease diagnosis and treatment fall within the practice of medicine, which Missouri excludes from chiropractic scope.[2][4] | Outside scope |
| Prescribing or managing peptide therapies (hormone/endocrine treatment) which is outside chiropractic scope. Rule: RSMo § 331.010 Missouri expressly bars chiropractors from administering or prescribing any drug or medicine, so prescribing or managing peptide/endocrine therapy is not within scope.[2][4] | Outside scope |
| Functional Neurology for neurological disease Rule: RSMo § 331.010 Even if a chiropractor uses non-drug methods, Missouri does not affirmatively authorize treatment of neurological disease as such under chiropractic scope.[2][4] | Outside scope |
| Internal Health for systemic disease Rule: RSMo § 331.010 Missouri chiropractic scope does not affirmatively authorize internal-health management of systemic disease, and the statute excludes the practice of medicine.[2][4] | Outside scope |
| Root-cause solutions for chronic disease Rule: RSMo § 331.010 A chronic-disease root-cause treatment claim is a medical management claim, and Missouri’s chiropractic statute does not affirmatively authorize that type of disease treatment.[2][4] | Outside scope |
Sources: Missouri State Board of Chiropractic Examiners – Statutes (official), Missouri Revised Statutes § 331.010 – Practice of chiropractic, definition, Missouri Revised Statutes § 331.030 – Application for license, requirements, fees (official), Revised Statutes of Missouri, RSMo Section 334.506 - MO.gov (official)
Scope comparison mirror
Side-by-side view of the archived marketing homepage and what a Chiropractor scope permits near SAINT LOUIS, MO. Open the mirror for the full comparison: archive on the left, permitted scope and licensed-care paths on the right.
Mirror generated 2026-07-17 06:28 UTC. The archive pane loads styles and images from the intake snapshot.
7 licensed-care paths linked for out-of-scope claims.
When the service is also outside their license
This pattern gets sharper when the service routed to your FSA or HSA also sits outside the practitioner's licensed scope. A provider advertising to diagnose or treat conditions their state board does not authorize is already operating past the edge of their license. Pair that with a cash-pay, FSA or HSA funded model that keeps the work away from any insurer or government program, and there is no claims reviewer, no audit trail, and no payer left to ask whether the care was appropriate or even within the provider's remit. The tax advantaged dollars do the paying, the patient carries the substantiation, and the scope question never reaches anyone with the authority to raise it.
Validated associated properties
Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.
Analyzed
- OwnedOfficial site (ericnepute.com)
- UnverifiedThird-party platform (instagram.com)
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission wLXHSnVAEXL8qcGJZhhpd
Fight disinformation
Log a public thread where Eric Nepute is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Eric Nepute's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/wLXHSnVAEXL8qcGJZhhpd. White-coat charisma isn't evidence.
Full DTMB scan on Eric Nepute: https://drtrustmebro.com/analyze/wLXHSnVAEXL8qcGJZhhpd
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
No conversation links logged yet. Be the first above.
Nudge the Doc Bro
We could not find a public contact email for Eric Nepute. Reach them through their own site and ask them to review this dossier and correct anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about Eric Nepute, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Eric Nepute. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: JvkGC2BA8MOe0UWKukuo7
- Wall entry: /influencer/JvkGC2BA8MOe0UWKukuo7
- Analysis ID: wLXHSnVAEXL8qcGJZhhpd
- Source: https://ericnepute.com/
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] PubMed indexed study
- [2] PubMed indexed study
- [3] PubMed indexed study
- [4] Comparison of rates of adherence to oral chemotherapy medications filled through an internal health-system specialty pharmacy vs external specialty pharmacies.
- [5] PubMed indexed study
- [6] PubMed indexed study
- [7] PubMed indexed study
- [8] PubMed indexed study
- [9] Guideline-Driven Management of Hypertension: An Evidence-Based Update.
- [10] What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis.
- [11] Table 2.
- [12] A Phase 2 Randomized Controlled Trial of Personalized Peptide Vaccine Immunotherapy with Low-dose Dexamethasone Versus Dexamethasone Alone in Chemotherapy-naive Castration-resistant Prostate Cancer - PubMed
- [13] A Phase 2 Randomized Controlled Trial of Personalized Peptide Vaccine Immunotherapy with Low-dose Dexamethasone Versus Dexamethasone Alone in Chemotherapy-naive Castration-resistant Prostate Cancer
- [14] Peptides as Therapeutic Agents: Challenges and Opportunities in ...
- [15] The efficacy of aquatic therapy in stroke rehabilitation: A protocol for systematic review and meta-analysis.
- [16] The State of the Evidence for Whole-System, Multi-Modality ...
- [17] P04.62. Systematic review of clinical studies of whole practice ...
- [18] Cochrane Systematic Reviews of Chinese Herbal Medicines: An Overview
- [19] Impact of Metabolic Dysfunction-Associated Fatty Liver Disease of Varying Severity on Antiviral Treatment Outcomes and Clinical Prognosis in Patients with Chronic Hepatitis B: A Systematic Review and Meta-analysis
- [20] PubMed indexed study